Indication
Solid Tumour
2 clinical trials
3 products
1 drug
Clinical trial
An Open-label, Fixed-sequence Study to Assess the Effect of Repeated Doses of Capivasertib on the Pharmacokinetics of Oral Midazolam (a CYP450 3A Probe) in Patients With Advanced Solid TumoursStatus: Completed, Estimated PCD: 2023-02-06
Product
MidazolamProduct
CapivasertibClinical trial
A Phase Ia/Ib, Open-Label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2027-02-28
Product
RO7759065Drug
Atezolizumab